Know4Nano

Andrew Piper’s research in the Merkoçi group focusses on the use of low-cost nanoelectrodes to develop point-of-care electrochemical tests for low concentration biomarkers. He is also actively involved in next generation lateral flow assay development, including the integration of electrical transducers into lateral flow assays. He also has experience and ongoing research interests in continuous and wearable biosensors.